Zhengyi Li - Publications

Schisandrin C suppresses melanoma growth and metastasis through modulation of Rap1-related and phosphatidylinositol 3-kinase/protein kinase B/mechanistic target of rapamycin signaling pathways.

Journal: Melanoma research

Published: March 27, 2026

Exploring the Active Components and Mechanisms of Schisandra Chinensis for Treatment of Non-small Cell Lung Cancer Based on Network Pharmacology and Experimental Validation.

Journal: Recent patents on anti-cancer drug discovery

Published: December 03, 2025

Schisandrin A alleviates UVB-induced photoaging via AMPK/Nrf2-mediated antioxidant and autophagy pathways.

Journal: Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology

Published: September 12, 2025

LINC00115 regulates lung adenocarcinoma progression via sponging miR-154-3p to modulate Sp3 expression.

Journal: Molecular and cellular probes

Published: December 04, 2022

Importance of N6-methyladenosine RNA modification in lung cancer (Review).

Journal: Molecular and clinical oncology

Published: December 27, 2020

Schisandrin B inhibits α-melanocyte-stimulating hormone-induced melanogenesis in B16F10 cells via downregulation of MAPK and CREB signaling pathways.

Journal: Bioscience, biotechnology, and biochemistry

Published: September 23, 2020

Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through the wingless/integrase-1 signaling pathway.

Journal: Experimental lung research

Published: May 05, 2020

Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.

Journal: Experimental lung research

Published: July 04, 2019